பீட்டர் மஂக் இதய News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பீட்டர் மஂக் இதய. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பீட்டர் மஂக் இதய Today - Breaking & Trending Today

Researchers discover deep learning model to maximise lifespan after liver transplant


Researchers discover deep learning model to maximise lifespan after liver transplant
ANI |
Updated: Apr 13, 2021 07:27 IST
Toronto [Canada], April 13 (ANI): Researchers from University Health Network have developed and validated an innovative deep learning model to predict a patient s long-term outcome after receiving a liver transplant.
This model is the result of a collaboration between the Ajmera Transplant Centre and Peter Munk Cardiac Centre. The study, published in Lancet Digital Health, shows it can significantly improve long-term survival and quality of life for liver transplant recipients.
Historically, we have seen good advances in one-year post-transplant outcomes, but survival in the longer term has not significantly improved in the past decades, said Dr Mamatha Bhat, a hepatologist with the Ajmera Transplant Centre at UHN and co-senior author of the study. ....

United States , Bo Wang , University Health Network , Ajmera Transplant Centre , Lancet Digital Health , Vector Institute , Peter Munk Cardiac Centre , Peter Munk Cardiac , Scientific Registry , Transplant Recipients , Transplant Centre , Liver Transplant , Deep Learning Method , Infection And Graft Failure , Latest Health Related Study , ஒன்றுபட்டது மாநிலங்களில் , போ வாங் , பல்கலைக்கழகம் ஆரோக்கியம் வலைப்பின்னல் , அஜ்மேற மாற்று மையம் , திசையன் நிறுவனம் , பீட்டர் மஂக் இதய மையம் , பீட்டர் மஂக் இதய , அறிவியல் பதிவு , மாற்று பெறுநர்கள் , மாற்று மையம் , கல்லீரல் மாற்று ,

Deep Learning model developed at UHN to maximize lifespan after liver transplant


 E-Mail
Toronto (April 12, 2021) - Researchers from University Health Network have developed and validated an innovative deep learning model to predict a patient s long-term outcome after receiving a liver transplant.
First of its kind in the field of Transplantation, this model is the result from a collaboration between the Ajmera Transplant Centre and Peter Munk Cardiac Centre. The study, published in
Lancet Digital Health, shows it can significantly improve long-term survival and quality of life for liver transplant recipients.
Historically, we have seen good advances in one-year post-transplant outcomes, but survival in the longer term hasn t significantly improved in the past decades, explains Dr. Mamatha Bhat, a hepatologist with the Ajmera Transplant Centre at UHN and co-senior author of the study. ....

United States , Emma King , Bo Wang , University Health Network , Senior Public Affairs Advisor , University Of Toronto , Public Affairs , Lancet Digital Health , Melanie Munk Charitable Foundation , Toronto Rehabilitation Institute , Peter Munk Cardiac Centre Ai Fund , Canadian Liver Foundation , Michener Institute Of Education , American Society Of Transplantation , Princess Margaret Cancer Centre , Ajmera Transplant Centre , Research Program , Vector Institute , Peter Munk Cardiac Centre , Peter Munk Cardiac , Mamatha Bhat , Scientific Registry , Transplant Recipients , Transplant Centre , American Society , Canadian Donation ,

Genetic testing proves beneficial in prescribing effective blood thinners


is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy and avoid side effects.
A new research paper funded in part by the National Heart, Lung and Blood Institute (NHLBI) shows a clear advantage of genetic testing in helping health care providers choose the appropriate anti-platelet drug. Testing helps determine if a patient carries genetic variants in CYP2C19 that cause loss of its function. These variants interfere with the body’s ability to metabolize and activate clopidogrel, an anti-platelet medication.
Anti-platelet drugs are given to prevent complications from blood clotting after a procedure to open clogged arteries. These patients can use one of the various anti-platelet medications, such as clopidogrel, ticagrelor or prasugrel. ....

Michael Farkouh , Naveen Pereira , Richard Weinshilboum , University Of Toronto , University Health Network Peter Munk Cardiac Centre , Mayo Center , National Heart , Mayo Clinic Center , Blood Institute , Cardiovascular Interventions , Individualized Medicine , Mayo Clinic , University Health Network , Peter Munk Cardiac , Public Release , Coronary Artery Disease , Clinical Trials , Genetic Testing , Multi National , Genomic Test , Heart Attack , Chest Pain , நவீன் பெரேரா , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , பல்கலைக்கழகம் ஆரோக்கியம் வலைப்பின்னல் பீட்டர் மஂக் இதய மையம் , மயோ மையம் ,